Strong Earnings Growth Lifted Novanta (NOVT) in Q4

2 days ago 8

Soumya Eswaran

Thu, February 19, 2026 astatine 6:39 AM CST 2 min read

Conestoga Capital Advisors, an plus absorption company, released its fourth-quarter 2025 capitalist letter. As galore believe, US equities experienced coagulated returns successful 2025, with double-digit gains crossed each large indices, yet underlying conditions revealed utmost volatility and marketplace leadership. A transcript of the missive tin beryllium downloaded here. In Q4 2025, Conestoga Capital Advisors Small Cap Strategy returned -1.89% net-of-fees, trailing the Russell 2000 Growth Index’s 1.22% return. The returns were volatile successful the quarter. The “low quality” stocks rally persisted successful the quarter, but astatine a slower gait compared to earlier quarters. Please reappraisal the Strategy’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Conestoga Capital Advisors highlighted Novanta Inc. (NASDAQ:NOVT). Novanta Inc. (NASDAQ:NOVT) is simply a exertion solutions institution that offers precision medicine, precision manufacturing, aesculapian solutions, robotics and automation solutions, and precocious country solutions. On February 18, 2026, Novanta Inc. (NASDAQ:NOVT) banal closed astatine $145.63 per share. One-month instrumentality of Novanta Inc. (NASDAQ:NOVT) was 5.29%, and its shares are up 1.98% implicit the past 12 months. Novanta Inc. (NASDAQ:NOVT) has a marketplace capitalization of $5.2 billion.

Conestoga Capital Advisors stated the pursuing regarding Novanta Inc. (NASDAQ:NOVT) successful its 4th fourth 2025 capitalist letter:

"Novanta Inc. (NASDAQ:NOVT) provides exertion solutions to aesculapian and precocious concern OEMs, specializing successful photonics, vision, and precision motion. The institution outperformed successful the 4th fourth pursuing a beardown net study highlighted by double-digit maturation successful its Advanced Surgery business. Management noted that bookings grew 17% twelvemonth over-year, signaling robust aboriginal request arsenic lawsuit inventory levels normalize. We judge NOVT’s quality to transcend nett expectations portion navigating a analyzable macro situation demonstrates the durability of its diversified, high-quality concern model."

Is Novanta Inc. (NOVT) the Best Scientific Instruments Stock to Buy Right Now?

Novanta Inc. (NASDAQ:NOVT) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 27 hedge money portfolios held Novanta Inc. (NASDAQ:NOVT) astatine the extremity of the 3rd quarter, the aforesaid arsenic successful the erstwhile quarter. While we admit the imaginable of Novanta Inc. (NASDAQ:NOVT) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article